Ridgewood, NJ, United States of America

Vern G DeVries

This inventor holds 18 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignee: American Cyanamid Company. Active years: 1983-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vern G DeVries. Retrieved from https://idiyas.com/inventor/vern-g-devries

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 8

Forward Citations = 201(Granted Patents)


Company Filing History:


Years Active: 1983-1994

Loading Chart...
Areas of Expertise:
Antidiabetic Phosphonates
Atherosclerosis Treatments
Arylglyoxals
Phosphates
Silanes
Dibenzocycloalkanamides
Diphenyl Alkanamides
Trisubstituted Ureas
Thioureas
Hypoglycemic Agents
Dialkylureas
18 patents (USPTO):Explore Patents

Title: Innovator and Inventor Vern G. DeVries: Pioneering Advances in Pharmaceutical Chemistry

Introduction

Vern G. DeVries is a prominent inventor based in Ridgewood, NJ, recognized for his significant contributions to pharmaceutical chemistry. With a remarkable portfolio of 18 patents, he has dedicated his career to enhancing drug formulations and therapeutic applications, particularly in the fields of diabetes and obesity treatment.

Latest Patents

Among his latest innovations, DeVries has developed substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles. This invention is noteworthy for its potential anti-diabetic, anti-hyperglycemic, and anti-obesity properties, demonstrating his commitment to advancing health solutions. Another patent he holds focuses on a process for obtaining the R,R isomer of substituted 5-(2-(2-aryl-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxoles. This specific innovation showcases his attention to detail and complex chemical structures, utilizing various groups to achieve significant therapeutic effects.

Career Highlights

Throughout his career, DeVries has worked at the American Cyanamid Company, where he has played a crucial role in research and development. His expertise in pharmaceutical chemistry has led to groundbreaking discoveries that aim to address critical health concerns. The dedication he demonstrates in his work has established him as a respected figure in the field of drug development.

Collaborations

DeVries has collaborated with notable coworkers, including Thomas H. Claus and Middleton B. Floyd, Jr. These partnerships have likely fueled innovative ideas and fostered a collaborative environment that enables the advancement of new technologies and products within the pharmaceutical industry.

Conclusion

Vern G. DeVries stands out as a key inventor whose contributions to pharmaceutical chemistry are evident through his numerous patents and innovative work. His latest inventions targeting vital health issues, combined with valuable collaborations, affirm his status as a trailblazer in the realm of drug development. Through ongoing research and dedication, DeVries continues to shape the future of medical solutions, benefiting both humans and animals alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…